Implications of the North Atlantic Oscillation for a UK–Norway renewable power system

UK wind-power capacity is increasing and new transmission links are proposed with Norway, where hydropower dominates the electricity mix. Weather affects both these renewable resources and the demand for electricity. The dominant large-scale pattern of Euro-Atlantic atmospheric variability is the North Atlantic Oscillation (NAO), associated with positive correlations in wind, temperature and precipitation over northern Europe. The NAO's effect on wind-power and demand in the UK and Norway is examined, focussing on March when Norwegian hydropower reserves are low and the combined power system might be most susceptible to atmospheric variations. The NCEP/NCAR meteorological reanalysis dataset (1948–2010) is used to drive simple models for demand and wind-power, and ‘demand-net-wind’ (DNW) is estimated for positive, neutral and negative NAO states. Cold, calm conditions in NAO− cause increased demand and decreased wind-power compared to other NAO states. Under a 2020 wind-power capacity scenario, the increase in DNW in NAO− relative to NAO neutral is equivalent to nearly 25% of the present-day average rate of March Norwegian hydropower usage. As the NAO varies on long timescales (months to decades), and there is potentially some skill in monthly predictions, we argue that it is important to understand its impact on European power systems.

Habitual energy expenditure modifies the association between NOS3 gene polymorphisms and blood pressue

BACKGROUND: The endothelial nitric-oxide synthase (NOS3) gene encodes the enzyme (eNOS) that synthesizes the molecule nitric oxide, which facilitates endothelium-dependent vasodilation in response to physical activity. Thus, energy expenditure may modify the association between the genetic variation at NOS3 and blood pressure. METHODS: To test this hypothesis, we genotyped 11 NOS3 polymorphisms, capturing all common variations, in 726 men and women from the Medical Research Council (MRC) Ely Study (age (mean +/- s.d.): 55 +/- 10 years, body mass index: 26.4 +/- 4.1 kg/m(2)). Habitual/non-resting energy expenditure (NREE) was assessed via individually calibrated heart rate monitoring over 4 days. RESULTS: The intronic variant, IVS25+15 [G-->A], was significantly associated with blood pressure; GG homozygotes had significantly lower levels of diastolic blood pressure (DBP) (-2.8 mm Hg; P = 0.016) and systolic blood pressure (SBP) (-1.9 mm Hg; P = 0.018) than A-allele carriers. The interaction between NREE and IVS25+15 was also significant for both DBP (P = 0.006) and SBP (P = 0.026), in such a way that the effect of the GG-genotype on blood pressure was stronger in individuals with higher NREE (DBP: -4.9 mm Hg, P = 0.02. SBP: -3.8 mm Hg, P= 0.03 for the third tertile). Similar results were observed when the outcome was dichotomously defined as hypertension. CONCLUSIONS: In summary, the NOS3 IVS25+15 is directly associated with blood pressure and hypertension in white Europeans. However, the associations are most evident in the individuals with the highest NREE. These results need further replication and have to be ideally tested in a trial before being informative for targeted disease prevention. Eventually, the selection of individuals for lifestyle intervention programs could be guided by knowledge of genotype.